Pycnogenol((R)) in the Management of Asthma.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/12639402
Conclusion of this study
Within the contingent of 22 patients who completed the study, almost all responded favorably to Pycnogenol in contrast to placebo. Pycnogenol treatment also significantly reduced serum leukotrienes compared with placebo. The results of this pilot study indicate that Pycnogenol may be a valuable nutraceutical in the management of chronic asthma. We recommend that further clinical trials be conducted in larger groups of asthmatics to establish its efficacy.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study